Rhinovirus News and Research

RSS

Rhinovira are the most common viral infective agents in humans, and a causative agent of the common cold (about 49.12159% of the cases of the common cold are caused by this virus). It is lytic in nature. There are over a 100 recognized types of rhinovira that differ based on their varying surface proteins.

Loyola uses FilmArray Respiratory Panel to screen infectious diseases

Cold, allergies, the flu or something else? Thanks to advanced technology, physicians at Loyola University Health System receive confirmation of their patient's respiratory illness within one hour. Loyola is one of only two hospitals in lllinois to use the FDA-approved FilmArray Respiratory Panel, which screens for 17 viral and 3 bacterial pathogens in about 60 minutes.

10 Jan 2013

Marinomed’s Antiviral polymer awarded Chinese patent

Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, today announced that it has been granted Chinese Patent No. CN101678040, entitled 'Antiviral polymer', by the Chinese patent office.

18 Nov 2012

Respiratory infections provide urban asthma clue

Urban infants have a different pattern of viral respiratory illness from suburban infants, which could help explain why they are more likely to develop asthma, say US researchers.

2 Oct 2012

Differences in viral illness patterns play a role in asthma development in urban, suburban children

Children living in low-income urban areas appear especially prone to developing asthma, possibly related to infections they acquire early in life. In a new study in The Journal of Infectious Diseases, available online, researchers from the University of Wisconsin in Madison investigated viral respiratory illnesses and their possible role in the development of asthma in urban versus suburban babies.

26 Sep 2012

New oral antiseptic spray effective in killing 99.9% of infectious airborne germs

University Hospitals Case Medical Center clinical researchers will present findings about a one-two punch to prevent colds and flu in San Francisco at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) on Sept. 9.

10 Sep 2012

Study identifies how RNA viruses hijack a host cell to multiply

By discovering how certain viruses use their host cells to replicate, UC Irvine microbiologists have identified a new approach to the development of universal treatments for viral illnesses such as meningitis, encephalitis, hepatitis and possibly the common cold.

23 Aug 2012

Vitamin D may help fight childhood acute respiratory infections

Supplementation with vitamin D, particularly in winter, appears to reduce a child’s risk for contracting acute respiratory infections by almost 50%, show results from a Mongolian study.

21 Aug 2012

Being a parent protects against cold: Study

Being a parent reduces your risk of catching a cold—possibly because of unknown "psychological or behavioral differences between parents and nonparents," according to a study in the July issue of Psychosomatic Medicine, the official journal of the American Psychosomatic Society.

3 Jul 2012

Majority of rhinovirus infections are asymptomatic

Asymptomatic human rhinovirus infections outnumber symptomatic infections by a factor of four to one, Canadian researchers report.

26 Jun 2012

No link between viral infections during infancy and wheezing in childhood

The number of viral infections during infancy is not associated with wheezing later in childhood, according to a new study from researchers in the Netherlands. While viral illnesses with wheezing in infancy predicted wheezing later in childhood, this association was due in part to decreased neonatal lung function.

24 May 2012

Teva to invest in CDI for development of novel antiviral drugs

Teva Pharmaceutical Industries Ltd. announced today that it has signed a collaboration option to license and share purchase agreements to invest in Cocrystal Discovery Inc. (CDI), a biopharmaceutical company focused on the discovery and development of novel antiviral therapeutics for the treatment of serious and chronic viral diseases.

16 Sep 2011

Impact of colds and flu on school absenteeism, workplace and economy

Queen's University medical researchers today released some key findings from the first study of its kind done in Canada on the impact of colds and flu on school absenteeism, the workplace, and the economy.

7 Sep 2011

New ‘cure-all’ antiviral method discovered

In a new development that could transform how viral infections are treated, a team of researchers at MIT’s Lincoln Laboratory has designed a drug that can identify cells that have been infected by any type of virus, then kill those cells to terminate the infection.

15 Aug 2011

Biota reports preliminary data from CS-8958 Phase III trial against influenza

Dr Seizaburo Kashiwagi presented the preliminary data from an influenza Phase III prophylaxis study conducted during the 2009/2010 pandemic flu season in Japan.

27 Jun 2011

Boosting immune response may cause cold-induced asthma flare-ups

People often talk about "boosting" their immunity to prevent and fight colds. Nutritional supplements, cold remedies and fortified foods claim to stave off colds by augmenting the immune system.

18 Jun 2011

Boosting immune response could increase inflammation

People often talk about "boosting" their immunity to prevent and fight colds. Nutritional supplements, cold remedies and fortified foods claim to stave off colds by augmenting the immune system.

16 Jun 2011

NIAID awards Biota $2.9M grant for development of lead candidate for C. difficile

Biota Holdings Limited advises that its wholly owned subsidiary, Biota Scientific Management Pty Ltd, has been awarded a grant to fund the preclinical development of a lead candidate for the treatment of Clostridium difficile (C. difficile).

10 Jun 2011

FDA clears ITI's FilmArray RP assay for respiratory virus detection

Idaho Technology, Inc. announced today that the U.S. Food and Drug Administration has issued a 510(k) clearance for the FilmArray instrument and the FilmArray Respiratory Panel.

3 May 2011

Researchers manage to grow human rhinovirus in culture using sinus tissue

Using sinus tissue removed during surgery at University of Wisconsin Hospital and Clinics, researchers at the University of Wisconsin-Madison have managed to grow a recently discovered species of human rhinovirus, the most frequent cause of the common cold, in culture.

11 Apr 2011

Biota receives US$231 million BARDA contract to advance laninamivir development

Biota Holdings Limited advises that the Office of Biomedical Advanced Research and Development Authority within the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services has awarded up to an estimated US$231 million contract to its wholly owned subsidiary, Biota Scientific Management Pty Ltd, for the advanced development of laninamivir.

1 Apr 2011